CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach-Reference-Cited by-同舟云学术

CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach

Published:2023-07-27 Issue:12 Volume:55 Page:1745-1764
ISSN:0939-4451
Container-title:Amino Acids
language:en
Short-container-title:Amino Acids

Author:

Durojaye Olanrewaju Ayodeji,Ejaz Umer,Uzoeto Henrietta Onyinye,Fadahunsi Adeola Abraham,Opabunmi Adebayo Oluwole,EKPO Daniel Emmanuel,Sedzro Divine Mensah,Idris Mukhtar Oluwaseun

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s00726-023-03304-2.pdf

Reference96 articles.

1. Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M (2021) PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA. Nucleic Acids Res 49(W1):W530–W534

2. Adjei AA, Mauer A, Bruzek L, Marks RS, Hillman S, Geyer S, Hanson LJ, Wright JJ, Erlichman C, Kaufmann SH (2003) Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non–small-cell lung cancer. J Clin Oncol 21(9):1760–1766

3. Ahinko M, Niinivehmas S, Jokinen E, Pentikäinen OT (2019) Suitability of MMGBSA for the selection of correct ligand binding modes from docking results. Chem Biol Drug Des 93(4):522–538

4. Ahmed MC, Crehuet R, Lindorff-Larsen K (2020) Computing, analyzing, and comparing the radius of gyration and hydrodynamic radius in conformational ensembles of intrinsically disordered proteins. Intrinsically disordered proteins. Springer, New York, pp 429–445

5. Alves VM, Muratov EN, Zakharov A, Muratov NN, Andrade CH, Tropsha A (2018) Chemical toxicity prediction for major classes of industrial chemicals: is it possible to develop universal models covering cosmetics, drugs, and pesticides? Food Chem Toxicol 112:526–534

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing drug discovery: an AI-powered transformation of molecular docking;Medicinal Chemistry Research;2024-06-14

2. Investigation of the MDM2-binding potential of de novo designed peptides using enhanced sampling simulations;International Journal of Biological Macromolecules;2024-06

3. In Silico Evaluation of Bioactive Compounds of Citrullus lanatus as Potential Noncovalent KRAS Inhibitors in the Treatment of Human Cancer;Chemistry Africa;2024-03-19

4. Enzyme inhibitors for drug discovery;Amino Acids;2023-11-28

5. CHAPERONg: A tool for automated GROMACS-based molecular dynamics simulations and trajectory analyses;Computational and Structural Biotechnology Journal;2023